Clinical Trials Update: June 16, 2006
Diabetes - Type 2 Rheumatoid Arthritis Prostate Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetes - Type 2
This is a research study for an investigational medication to treat type 2 diabetes. Candidates 30 to 75 may be included if they have had type 2 diabetes for at least one year and are taking metformin to control blood sugar. Participants will receive study-related care and study medication at no charge and may receive compensation up to $515 for time and travel.
The research site is in Columbus, Ohio.
This study will evaluate the safety and efficacy of an investigational drug for active rheumatoid arthritis. Candidates 18-80 who have been diagnosed with rheumatoid arthritis for a minimum of six months and currently have active RA symptoms may be eligible. Participants must have an inadequate response to methotrexate, dose and duration per protocol specifics.
The research site is in Worcester, Mass.
This study will compare the duration of survival between the GVAX® prostate cancer vaccine and chemotherapy. Volunteers must have diagnosis of or clinical history consistent with adenocarcinoma of the prostate, cancer that is deemed unresponsive or refractory to hormone therapy, and cancer that has spread outside the prostate. Participants must have had no prior treatment with chemotherapy, gene therapy, immunotherapy, or significant cancer related pain.
Research sites are located throughout the United States, Canada, Belgium, and England.
Copyright 2006 Thomson CenterWatch. All rights reserved.